Biotech Experiences Strong Open Following Major Announcement
10 Juillet 2024 - 4:35PM
AllPennyStocks.com
An Australian biotech company is already
turning heads so far on Wednesday after it was announced results
from its GBM-AGILE, which is a phase II/III study that included
an...
To read the full story on AllPennyStocks.com, click
here.
Kazia Therapeutics (NASDAQ:KZIA)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Kazia Therapeutics (NASDAQ:KZIA)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025
